Back to today’s briefing

Story perspectives

Revolutionary AI Model Transforms Cancer Treatment Predictions

1/8/2025

42 8

Summary

Story summary

A groundbreaking AI model named SCORPIO, created by researchers at Memorial Sloan Kettering Cancer Center and Mount Sinai, predicts how cancer patients will respond to immune checkpoint inhibitors through simple blood tests. This innovative tool surpasses current FDA-approved biomarkers, paving the way for more accessible and cost-effective cancer treatment, and holds the promise of transforming care for patients worldwide.

1 of 1

Story summary

A groundbreaking AI model named SCORPIO, created by researchers at Memorial Sloan Kettering Cancer Center and Mount Sinai, predicts how cancer patients will respond to immune checkpoint inhibitors through simple blood tests. This innovative tool surpasses current FDA-approved biomarkers, paving the way for more accessible and cost-effective cancer treatment, and holds the promise of transforming care for patients worldwide.